Piscataway, NJ, August 7, 2023–Camber Pharmaceuticals is pleased to announce the addition of Ketorolac Tromethamine Tablets, USP to its current portfolio.
Ketorolac Tromethamine Tablets are indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine, and Ketorolac Tromethamine Tablets are to be used only as continuation treatment, if necessary.
Ketorolac Tromethamine, USP 10 mg are available in 100 count bottles.
To find out more about Ketorolac Tromethamine Tablets, USP please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
